1.8BUSD
Type
Common Stock
Exchange
OTCQX
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
14.78
Dividend Share
-
Dividend Yield
-
Earnings Share
-35.64
Wall Street Target Price
40.00
EPS Estimate Current Year
2.31
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0.544
EPS Estimate Next Quarter
0.786
Most Recent Quarter
-
Revenue TTM
1,733,465,984
Gross Profit TTM
274,827,008
EBITDA
-79,375,000
Profit Margin
326.98%
Return On Assets TTM
-5.38%
Return On Equity TTM
0.00%
Revenue Per Share TTM
20.169
Qtly Revenue Growth YOY
-6.40%
Diluted Eps TTM
-35.64
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
10
Price Sales TTM
1.0385
Price Book MRQ
1.5985
Enterprise Value Revenue
1
Enterprise Value EBITDA
0
139.41
4.21%27.60
0.69%86.88
0.48%28.36
0.00%34.52
0.00%193.90
-6.37%119.04
-1.43%31.28
-1.03%9.59
-0.86%17.75
-0.70%